Studies on Diffusion Chamber for Bio-artificaial Endocrine Pancreas

生物人工内分泌胰腺扩散室的研究

基本信息

  • 批准号:
    60480311
  • 负责人:
  • 金额:
    $ 3.84万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
  • 财政年份:
    1985
  • 资助国家:
    日本
  • 起止时间:
    1985 至 1987
  • 项目状态:
    已结题

项目摘要

Bio-artificial endocrine pancreas (Bio-AEP) containing islet cells is more capable of curing the homeostasis of diabetic patients than mechamical insulin delivery system from the long term physiological viewpoint. Islet cells separated from mouse or rat pancreas were cultured in monolayer with 3 isobuty1-1-methylxanthine (IBMX) added to medium, so as to keep ptheir viability to secrete insulin and other hormons in response to glucose concentration for a long period. Monolayer cells cultured on plastic plate should be enclosed with semipermeable polymer membrane in order to block the passing of immunoglobulins and lymphocytes inducing the host's immune reaction. At the same time polymer membrane should pass such useful substances as glucose, insulin and albumin.An implantable diffusion chamber for Bio-AEP was developed, which consisted of a small size holder, a culture plate with monolater islet cells and polymer membranes envelopping culture plate. Bio-AEP using mouse or rat islet cells were implanted into intraperitoneal cavities of mice. In case of isograft (mouse to mouse) implantation, glucose metabolism of diabetic animal recovered to mormal state for 100 days. However, in case of xenograft islets (rat to mouse), hyperglycemia of diabetic animal was slightly relieved only for 60 days. The passage of immunological substances was suspected as the cause of insufficient function of exnograft. The semipermeable membrane envelopping culture cells is key point of diffusion chamber type Bio-AEP Synthetic nuclepore and fluoropore membrane (pore size 0.03 - 0.6 <mu>m, membrane thickness 10 - 50 <mu>m) and capsule membrane of rabbit kidney were examined on their pormability of insulin, albumin and <gamma>-globulin. The result of experiment indicated that nuclepore of 0.03 <mu>m pore size and capsule membrane of kidney were preferable to others. The further biocompatible membrane should be developed in the field of biomaterials' science.
含胰岛细胞的生物人工内分泌胰腺(Bio-artificial endocrine pancreas,Bio-AEP)从长期生理学角度看比机械胰岛素输送系统更能改善糖尿病患者的内环境稳定。从小鼠或大鼠胰腺分离的胰岛细胞在单层培养中加入3-异丁基-1-甲基黄嘌呤(IBMX),以保持其对葡萄糖浓度的反应性,从而使胰岛细胞能长期分泌胰岛素和其它胰岛素。单层细胞在塑料板上培养时,应采用半透性高分子膜封闭,以阻断免疫球蛋白和淋巴细胞的通过,从而诱导宿主的免疫反应。研制了一种用于Bio-AEP的可植入式扩散室,该扩散室由小型保持器、单层胰岛细胞培养板和覆盖培养板的高分子膜组成。将使用小鼠或大鼠胰岛细胞的Bio-AEP植入小鼠的腹腔内。在同种移植物(小鼠到小鼠)植入的情况下,糖尿病动物的葡萄糖代谢在100天内恢复到正常状态。然而,在异种移植胰岛的情况下(大鼠到小鼠),糖尿病动物的高血糖仅在60天内轻微缓解。免疫物质的通过被怀疑是移植物功能不全的原因。半透性膜分离培养细胞是Bio-AEP扩散室的关键。本文研究了合成核孔膜、荧光孔膜(孔径0.03 - 0.6 <mu>μ m,膜厚10 - 50 <mu>μ m)和兔肾包膜膜对胰岛素、白蛋白和<gamma>β-球蛋白的渗透性。实验结果表明,以0.03 μ m孔径的核孔<mu>和肾包膜为最佳。生物相容性膜是生物材料科学研究的一个重要领域。

项目成果

期刊论文数量(31)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
H.Ohtawara: "A Comparative Study of Insuline Selection from Pancreatic Islets Maintained in Free-floating and Monolater Culture." J. Japan Diab. Soc.28. 537-542 (1985)
H.Ohtawara:“自由漂浮和单层培养中维持的胰岛的胰岛素选择的比较研究”。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
大河原久子: 人工臓器. 15-6. 1941-1944 (1986)
大河原久子:人造器官15-6 1941-1944(1986)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
大河原久子: 人工臓器. 15-3. 1497-1500 (1986)
大河原久子:人造器官15-3 1497-1500 (1986)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
大河原久子: 移植. 22-5. 576-577 (1987)
大河原久子:移植。22-5576-577(1987)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
H.Ohgawara: "A Possibitity of Iso- and Xenograft Pancreatic Is let Implantation by Using a Deffusion Chamber." Jpn. J. Artif. Organs. 15-6. 1941-1944 (1986)
H.Ohkawara:“通过使用扩散室进行同种和异种移植胰腺的可能性。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SAKURAI Yasuhisa其他文献

SAKURAI Yasuhisa的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SAKURAI Yasuhisa', 18)}}的其他基金

Preparation of Glucose-Responsive Phenylboronic Acid-Containing Polymers and Their Application to Artificial Pancreas
葡萄糖响应性含苯基硼酸聚合物的制备及其在人工胰腺中的应用
  • 批准号:
    07559020
  • 财政年份:
    1995
  • 资助金额:
    $ 3.84万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Design of Temperature-Responsive Surfaces and Its Application for Aqueous Chromatography
温度响应表面的设计及其在水色谱中的应用
  • 批准号:
    07408030
  • 财政年份:
    1995
  • 资助金额:
    $ 3.84万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
In Vitro and in Vivo Nonthorombogenicity of Microdomain Polymers
微域聚合物的体外和体内非血栓形成性
  • 批准号:
    01490023
  • 财政年份:
    1989
  • 资助金额:
    $ 3.84万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
Research and development of the small caliber artificial blood vessel with antithrombogenicity
具有抗血栓形成作用的小口径人工血管的研发
  • 批准号:
    58870070
  • 财政年份:
    1983
  • 资助金额:
    $ 3.84万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了